Study Summary
This trial tests a lotion to improve hair growth, reduce scalp itch, and improve scalp psoriasis in 12 weeks. Patients' perceptions of the lotion's value are also assessed.
Eligible Conditions
- Scalp Psoriasis
Treatment Effectiveness
Phase-Based Effectiveness
Phase 4
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 12 weeks
12 weeks
Hair Growth
Scalp Itch
Trial Safety
Phase-Based Safety
This is further along than 85% of similar trials
Awards & Highlights
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
0 Treatment Group
20 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks
Who is running the clinical trial?
Dermatology Consulting Services, PLLCLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Ortho DermatologicsIndustry Sponsor
4 Previous Clinical Trials
1,236 Total Patients Enrolled
Zoe D Draelos, MDPrincipal InvestigatorDermatology Consulting Services, PLLC
4 Previous Clinical Trials
229 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: